Theriva Biologics, Inc. (TOVX) Tops Q1 EPS by 4c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q1 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c